Polen Capital Management »

Denali Therapeutics shares owned by Polen Capital Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Polen Capital Management from 13F filings

Historical chart of Polen Capital Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Polen Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Polen Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $444k 27k 16.51

More positions owned by Polen Capital Management

Amazon (AMZN)
Microsoft Corporation (MSFT)
Oracle Corporation (ORCL)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Visa Com Cl A (V)
Shopify Cl A Sub Vtg Shs (SHOP)
NVIDIA Corporation (NVDA)
Servicenow (NOW)
Msci (MSCI)
Zoetis Cl A (ZTS)
Aon Shs Cl A (AON)
IDEXX Laboratories (IDXX)

View all positions for Polen Capital Management

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
FMR
State Street Corporation
Temasek Holdings
Norges Bank Investment Management
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Capital Research Global Investors
Alliancebernstein
Geode Capital Management
Holocene Advisors

View all funds holding Denali Therapeutics